Traphaco High Tech JSC
UUPCOM:CNC29,800.00
VND
+800.00
(+2.76%)
ISIN
VN000000CNC9
Return %
Stock
S&P 500
1Y
-9.42
14.20
3Y
-0.67
81.12
5Y
-5.40
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Hung Yen Vietnam
- IPO Date
- Jun 25, 2014
- Website
- traphacocnc.com
- Similar Companies
- Business
- Traphaco High Tech Joint Stock Company is a Vietnam-based pharmaceutical manufacturing company primarily engaged in the research, development, industrial extraction, and production of modern herbal medicines, traditional phytotherapeutic drugs, dietary supplements, and health beverages. Established in 2006 and officially commencing operations in 2007, the company is headquartered in Van Lam District, Hung Yen Province, Vietnam, and operates as a core production subsidiary of Traphaco Joint Stock Company, which holds a controlling 51 percent equity stake. Traphaco High Tech JSC supplies prescription and over-the-counter phytopharmaceuticals to retail pharmacy chains, hospitals, medical clinics, and consumer healthcare channels across Vietnam through the parent company's nationwide distribution network. The company's commercial portfolio and manufacturing capabilities are structured around specialized therapeutic categories, dosage forms, and industrial services, comprising: hepatoprotective and liver detoxification medications, featuring the flagship Boganic product line offered in soft capsules, film-coated tablets, and sugar-coated pills; cerebral circulation and neurovascular therapeutics, headlined by the Hoat Huyet Duong Nao and Cebraton herbal formulations for memory enhancement and cerebrovascular insufficiency; anorectal and vein health treatments, anchored by the Tottri brand in hard capsule and granule dosage forms; traditional compounded remedies and wellness pills, including Doc Hoat Tang Ky Sinh for musculoskeletal disorders, Luc Vi Dia Hoang, Thap Toan Dai Bo, and herbal sedative formulations; functional herbal teas and granular beverages, including instant ginger and fallopia multiflora teas; pharmaceutical raw materials, covering standardized botanical extracts, active herbal fractions, and refined spray-dried powders; and contract manufacturing and analytical testing services, encompassing third-party toll manufacturing, automated sugar-coating, fluidized-bed drying, softgel encapsulation, and quality control assaying for pharmaceutical, cosmetic, and health food enterprises. In recent developments, Traphaco High Tech JSC has implemented substantial production upgrades and technological modernization across its Hung Yen manufacturing hub to support expanded production volumes and stringent quality standards. The company has constructed and commissioned a new modern quality testing center compliant with Good Laboratory Practice (GLP-WHO) standards and completed the capacity expansion of its specialized softgel capsule manufacturing workshop. Additionally, the company has integrated advanced automated equipment, including high-capacity spray-drying systems and automated sugar-coating lines, while expanding its network of Good Agricultural and Collection Practices (GACP-WHO) certified medicinal herb cultivation zones to eight domestic regions to secure sustainable, traceable raw material supply chains. The company has maintained continuous operational alignment with Traphaco Group's green value chain and dual-platform development strategy, earning recognition as an Outstanding Enterprise in Green Environment and Energy and receiving national pharmaceutical industry distinctions for its flagship herbal drug lines.